Cargando…

Uses of 3-(2-Bromoacetyl)-2H-chromen-2-one in the Synthesis of Heterocyclic Compounds Incorporating Coumarin: Synthesis, Characterization and Cytotoxicity

In this work, 3-bromoacetylcoumarin was used as the key starting material for the synthesis of pyran, pyridine, thiophene, thiazole and pyrazole derivatives through its reaction with different reagents. The structures of the newly synthesized compounds were confirmed on the basis of their spectral d...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohareb, Rafat M., MegallyAbdo, Nadia Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272230/
https://www.ncbi.nlm.nih.gov/pubmed/26111181
http://dx.doi.org/10.3390/molecules200611535
_version_ 1783377107761496064
author Mohareb, Rafat M.
MegallyAbdo, Nadia Y.
author_facet Mohareb, Rafat M.
MegallyAbdo, Nadia Y.
author_sort Mohareb, Rafat M.
collection PubMed
description In this work, 3-bromoacetylcoumarin was used as the key starting material for the synthesis of pyran, pyridine, thiophene, thiazole and pyrazole derivatives through its reaction with different reagents. The structures of the newly synthesized compounds were confirmed on the basis of their spectral data and elemental analyses. All of the synthesized compounds were screened for their in vitro anticancer activity against six human cancer cell lines, namely: human gastric cancer (NUGC), human colon cancer (DLD1), human liver cancer (HA22T and HEPG2), nasopharyngeal carcinoma (HONE1), human breast cancer (MCF) and normal fibroblast cells (WI38). The IC(50) values (the sample concentration that produces 50% reduction in cell growth) in nanomolars (nM)) showed most of the compounds exhibited significant cytotoxic effect. Among these derivatives, compound 6d showed almost equipotent cytotoxic activity against NUGC (IC(50) = 29 nM) compared to the standard CHS 828 (IC(50) = 25 nM).
format Online
Article
Text
id pubmed-6272230
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62722302018-12-31 Uses of 3-(2-Bromoacetyl)-2H-chromen-2-one in the Synthesis of Heterocyclic Compounds Incorporating Coumarin: Synthesis, Characterization and Cytotoxicity Mohareb, Rafat M. MegallyAbdo, Nadia Y. Molecules Article In this work, 3-bromoacetylcoumarin was used as the key starting material for the synthesis of pyran, pyridine, thiophene, thiazole and pyrazole derivatives through its reaction with different reagents. The structures of the newly synthesized compounds were confirmed on the basis of their spectral data and elemental analyses. All of the synthesized compounds were screened for their in vitro anticancer activity against six human cancer cell lines, namely: human gastric cancer (NUGC), human colon cancer (DLD1), human liver cancer (HA22T and HEPG2), nasopharyngeal carcinoma (HONE1), human breast cancer (MCF) and normal fibroblast cells (WI38). The IC(50) values (the sample concentration that produces 50% reduction in cell growth) in nanomolars (nM)) showed most of the compounds exhibited significant cytotoxic effect. Among these derivatives, compound 6d showed almost equipotent cytotoxic activity against NUGC (IC(50) = 29 nM) compared to the standard CHS 828 (IC(50) = 25 nM). MDPI 2015-06-23 /pmc/articles/PMC6272230/ /pubmed/26111181 http://dx.doi.org/10.3390/molecules200611535 Text en © 2015 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mohareb, Rafat M.
MegallyAbdo, Nadia Y.
Uses of 3-(2-Bromoacetyl)-2H-chromen-2-one in the Synthesis of Heterocyclic Compounds Incorporating Coumarin: Synthesis, Characterization and Cytotoxicity
title Uses of 3-(2-Bromoacetyl)-2H-chromen-2-one in the Synthesis of Heterocyclic Compounds Incorporating Coumarin: Synthesis, Characterization and Cytotoxicity
title_full Uses of 3-(2-Bromoacetyl)-2H-chromen-2-one in the Synthesis of Heterocyclic Compounds Incorporating Coumarin: Synthesis, Characterization and Cytotoxicity
title_fullStr Uses of 3-(2-Bromoacetyl)-2H-chromen-2-one in the Synthesis of Heterocyclic Compounds Incorporating Coumarin: Synthesis, Characterization and Cytotoxicity
title_full_unstemmed Uses of 3-(2-Bromoacetyl)-2H-chromen-2-one in the Synthesis of Heterocyclic Compounds Incorporating Coumarin: Synthesis, Characterization and Cytotoxicity
title_short Uses of 3-(2-Bromoacetyl)-2H-chromen-2-one in the Synthesis of Heterocyclic Compounds Incorporating Coumarin: Synthesis, Characterization and Cytotoxicity
title_sort uses of 3-(2-bromoacetyl)-2h-chromen-2-one in the synthesis of heterocyclic compounds incorporating coumarin: synthesis, characterization and cytotoxicity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272230/
https://www.ncbi.nlm.nih.gov/pubmed/26111181
http://dx.doi.org/10.3390/molecules200611535
work_keys_str_mv AT moharebrafatm usesof32bromoacetyl2hchromen2oneinthesynthesisofheterocycliccompoundsincorporatingcoumarinsynthesischaracterizationandcytotoxicity
AT megallyabdonadiay usesof32bromoacetyl2hchromen2oneinthesynthesisofheterocycliccompoundsincorporatingcoumarinsynthesischaracterizationandcytotoxicity